Analysis of Inhaled Corticoid Prescriptions in General Medicine (COMEGE)
Status
Conditions
Study type
Funder types
Identifiers
Details and patient eligibility
About
Chronic obstructive pulmonary disease (COPD) and asthma are frequent and disabling pathologies. The general practitioner is often at the front line vis-a-vis screening, diagnosis and treatment of these pathologies. There are currently many treatments available, in particular inhaled corticosteroids, and although the recommendations for management appear to be well codified in theory, the adaptation of drug therapy remains complex in general practice.
The prescription of inhaled corticosteroids, often initiated during a general medicine consultation, is not simple. The aim of this study is to analyze the relevance of the prescription of inhaled corticosteroids in primary care and to identify the criteria necessary for the prescription of inhaled corticosteroids available in general practice.
The main objective of our study is to evaluate the rate of consultations where all the elements required for guiding the prescription of an inhaled corticoid are available.
The secondary objectives are:
- Identify other factors associated with decision-making
- Identify the causes of inhaled corticosteroid stopping (de-prescription)
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patient with short-term inhaled corticosteroid therapy
- Informed and not opposed to participate in this research
Exclusion criteria
- Patient under judicial or legal protection
- Adults under any kind of guardianship -
Trial design
80 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal